Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers

Br J Haematol. 2008 Sep;142(6):991-2. doi: 10.1111/j.1365-2141.2008.07206.x. Epub 2008 Jul 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Sickle Cell / complications*
  • Antihypertensive Agents / therapeutic use
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Female
  • Humans
  • Leg Ulcer / drug therapy*
  • Middle Aged
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Sulfonamides
  • Bosentan